Skip to main content
All lobbying filings

TREMONT STRATEGIES GROUP LLC (F/K/A ADS VENTURES)

TREMONT STRATEGIES GROUP LLC (F/K/A ADS VENTURES) filed a Q2 report for PROLACTA BIOSCIENCE, INC. on July 20, 2026, reporting $60,000 in lobbying income.

Lobbying for PROLACTA BIOSCIENCE, INC. · Standardized human milk-based nutritional products for premature infants in the NICU

All filings by TREMONT STRATEGIES GROUP LLC (F/K/A ADS VENTURES) · Everything PROLACTA BIOSCIENCE, INC. has reported

 Filing · LD-2 quarterly report Q2 report
Reporting period
2nd Quarter 2026
Apr 1 - June 30 · Posted Jul 20, 2026
Income
$60,000
What the client paid this registrant for the period.
Client based in
California

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 3

FDA Appropriations; FDA industry oversight.

Appropriations.

Advocacy in support of safety in human milk market. Access to Donor Milk Act. Infant formula and HR 2300.

 Bills named in this filing 1
  • H.R. 2300
    To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other pu…

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem